Podcast Short 1:03 August 26, 2026From Season 2, Episode 5

Why Mid-Revenue Cycle AI Success Depends on Leading Indicators

TM
Tami McMasters Gomez·Executive Director of Mid-Revenue Cycle, UC Davis Health
In this clip

Tami McMasters Gomez outlines the KPI framework UC Davis Health is building to evaluate mid-revenue cycle AI: medical necessity denial rates, first-pass claim acceptance tied to mid-rev cycle edits, avoidable denial dollars prevented, reduction in targeted denials, and fewer retrospective authorizations. A key design principle is weighting the framework toward leading indicators rather than lagging ones. By the time a denial appears in the data, the window to prevent it has already closed. The approach is to establish a baseline without the technology and then measure the same indicators after implementation, creating a clear before-and-after that demonstrates whether the AI investment is yielding ROI.

Key Takeaway

Measuring mid-revenue cycle AI on denial rates alone captures the outcome too late. The right framework leads with upstream indicators: first-pass acceptance, avoidable denial prevention, and authorization patterns. Establishing a pre-technology baseline and tracking the same metrics after implementation is what determines whether the investment is paying off.

“By the time you see a denial, it’s already too late. So we’re emphasizing leading indicators: being more proactive rather than reactive.”

Tami McMasters Gomez, Executive Director of Mid-Revenue Cycle, UC Davis Health

Claims Denial ManagementAgentic AI
From the full episode

Listen to the full conversation.

Tami McMasters Gomez
Season 2 · Episode 5 · 37 min

Denials Prevention at the Source: Autonomous Coding, CDI, and AI Governance in the Mid-Revenue Cycle

Tami McMasters Gomez · Executive Director of Mid-Revenue Cycle, UC Davis Health

Tami McMasters Gomez describes how she leads the mid-revenue cycle at UC Davis Health as a proactive control point focused on denials prevention at the source, stopping revenue loss before claims are ever coded or dropped. She explains the framework she uses to anchor priorities around authorization accuracy, real-time clinical documentation integrity, and upstream claims denial management, and describes the bold decision to discontinue the CDI and coding reconciliation process, which drove a 33 percent increase in productivity alongside coding accuracy near 99.9 percent. The conversation covers two active autonomous coding implementations across radiology and outpatient evaluation and management coding, the human-in-the-loop quality assurance model that governs AI accuracy thresholds and direct-to-bill decisions, and the write-off avoidance task force she built to create cross-functional alignment among patient access, clinical, mid-cycle, and back-end teams. Tami also shares her perspective on where agentic AI will create transformational impact in the mid-revenue cycle through denials management automation and embedded clinical workflow intelligence, the governance challenges introduced by California legislation restricting AI in clinical decision-making, and the leadership philosophy she draws from trust-based relationships and empathic change management.

Spotify Apple YouTube
Listen to the full episode
Request a demo

Let’s redefine financial engagement together.

See how ArceeHQ can supercharge your revenue cycle. We’ll walk through the platform, discuss your specific systems and goals, and show measurable lift you can expect in the first 90 days.

Reply within 24 hoursNo spam, ever

We’ll never share your information.